Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2010
11/03/2010EP1005376B1 Compositions for use in gene therapy for treatment of hemophilia
11/03/2010EP0961837B1 Chimeric antisense oligonucleotides
11/03/2010CN1551783B Use of analog K121 antibody in preparing medicine for K type multiple myeloma
11/03/2010CN1244215B Improved method for the production and purification of adenoviral vectors
11/03/2010CN101875931A siRNA recombinant slow virus for inhibiting human hephaestin gene expression and application
11/03/2010CN101875918A Recombinant adenovirus of human hephaestin gene, preparation method thereof and application thereof
11/03/2010CN101875696A Antibody, and preparation method and application thereof
11/03/2010CN101875695A Antibody, and coding gene and application thereof
11/03/2010CN101875693A Albumin variant having anti-angiogenesis activity and preparation method thereof
11/03/2010CN101874898A General trivalent gene recombination vaccine for preventing infection of leptospira interrogans of different sero-groups and preparation method thereof
11/03/2010CN100998873B Gone medicine for preventing and treating mammitis of animal
11/02/2010US7825236 Phosphodiesterase inhibitor for treatment and prevention of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis
11/02/2010US7825228 Bone mineralization proteins, DNA, vectors, expression systems
11/02/2010US7825100 sequence complementary to GRP78 forms a special hair-pin structure inside cancer cells to specifically and effectively inhibit GRP78 expression and then inhibit the canceration process, including the growth, migration, invasion, and metastasis of cancer
11/02/2010US7825099 Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
11/02/2010US7825097 Nucleotide vector vaccine for immunization against hepatitis
11/02/2010US7824907 Expression vectors comprising the mCMV IE2 promoter
11/02/2010US7824860 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
11/02/2010US7824680 Methods for inhibiting angiogenesis
11/02/2010US7824670 Use of il6r/il6 chimera in nerve cell regeneration
11/02/2010CA2607214C Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/02/2010CA2337422C Preventing airway mucus production by administration of egf-r antagonists
11/02/2010CA2225998C Gene preparations containing biocompatible material for sustained release in gene therapy
10/2010
10/28/2010WO2010123983A1 Compostions and methods for targeted gene therapy
10/28/2010WO2010123798A2 Compositions for transfection of biomolecules into cells
10/28/2010WO2010123699A2 Compositions, kits and methods for promoting ischemic and diabetic wound healing
10/28/2010WO2010123648A2 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction
10/28/2010WO2010123501A1 Innate immune suppression enables repeated delivery of long rna molecules
10/28/2010WO2010123365A1 Increasing the immunogenicity of epithelial cells infected with human papilloma virus (hpv)
10/28/2010WO2010123156A1 Angiogenesis inhibitor
10/28/2010WO2010123136A1 Association of htra1 mutations and familial ischemic cerebral small-vessel disease
10/28/2010WO2010123065A1 Cancer antigen helper peptide
10/28/2010WO2010122961A1 Method for preparing cell pharmaceutical
10/28/2010WO2010065630A3 Compositions and methods for treating hepatic neoplasia
10/28/2010WO2010042755A3 Chimeric therapeutics, compositions, and methods for using same
10/28/2010WO2010042751A3 Chimeric therapeutics, compositions, and methods for using same
10/28/2010WO2010042749A3 Chimeric therapeutics, compositions, and methods for using same
10/28/2010US20100273998 Methods and compositions for modulating tissue factor
10/28/2010US20100273996 Method
10/28/2010US20100273990 Notch-based fusion proteins and uses thereof
10/28/2010US20100273866 Diagnosis and treatment of cancer: i
10/28/2010US20100273865 Polypeptides involved in neuronal regeneration-associated gene expression
10/28/2010US20100273864 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273708 Adiponectin expression-inducing agents and uses thereof
10/28/2010US20100273274 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
10/28/2010US20100273265 for inducing differentiation into retinal photoreceptor cells; for preventing/treating/suppressing progression of retinal diseases; retinitis pigmentosa, senile macular degeneration, diabetic retinopathy, retinal detachment, glaucoma and retinal vessel occlusion
10/28/2010US20100273174 Antibodies to tumor associated proteins
10/28/2010US20100272749 Optimized expression of HPV 58 L1 in yeast
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272688 Method of treating or retarding the development of blindness
10/28/2010CA2759608A1 Methods for mitochondrial dna replacement in oocytes
10/28/2010CA2759457A1 Association of htra1 mutations and familial ischemic cerebral small-vessel disease
10/28/2010CA2759181A1 Innate immune suppression enables repeated delivery of long rna molecules
10/28/2010CA2757764A1 Cancer antigen helper peptide
10/27/2010EP2243837A1 Carotene synthase gene and uses therefor
10/27/2010EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
10/27/2010EP2243786A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010EP1112088B1 Method for detecting connective tissue growth factor for diagnosing a renal disorder
10/27/2010EP0979101B1 Recombinant canine adenovirus 2 (cav2) containing exogenous dna
10/27/2010CN1942583B Optimized expression of HPV 58 L1 in yeast
10/27/2010CN1912141B Identification of genes
10/27/2010CN101873867A High concentration chitosan-nucleic acid polyplex compositions
10/27/2010CN101873866A Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
10/27/2010CN101870978A Clostridium difficile exotoxin A carboxy-terminal gene sequence with optimized codon and nucleic acid vaccine thereof
10/27/2010CN101869716A System for monitoring bacterial tumor treatment
10/27/2010CN101869715A Cell particles carrying interfering ribonucleic acid (RNA), preparation method and application thereof
10/27/2010CN101869714A Therapeutic agent for infections
10/27/2010CN101869575A Modulation of WRN-mediated telomere-initiated cell signaling
10/27/2010CN101579527B HLA Specific human cytomegalovirus Multi-epitope adenovirus DNA Vaccine of Chinese population
10/27/2010CN101297967B Novel use of staphylococcus enterotoxin A gene
10/27/2010CN101173290B Chemically synthesized HSV1 virus gB glucoprotein extracellular region gene fragment, representation and application of the same
10/26/2010US7820809 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition
10/26/2010US7820808 Antisense agent which prevents DNA replication
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820786 Synthetic peptides and uses therefore
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820635 Therapy for cancer; Alzheimer's disease; using Rna sequences; control degradation , block translation of messenger Rna ; transcription product of target gene encoding clusterin
10/26/2010US7820634 contacting cells in vivo with composition comprising collagenous matrix of submucosa tissue delaminated from both tunica muscularis and luminal portion of tunica mucosa of warm-blooded vertebrates, and added exogenous deoxyribonucleic acid
10/26/2010US7820632 For inhibiting expression of human immunodeficiency virus (HIV); for use in vitro/vivo
10/26/2010US7820624 which bind to human immature dendritic cells; non-viral transfection mixture comprising lipid component, polycationic nucleic acid-binding component, and peptide; gene expression inhibition; kits
10/26/2010US7820440 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
10/26/2010US7820438 Primary cultured adipocytes for gene therapy
10/26/2010US7820436 Genetic engineered herpes virus genomes; vaccine; gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus
10/26/2010US7820379 Process for high throughput screening of CpG-based immuno-agonist/antagonist
10/26/2010US7820375 Use of a protein of the CRMP family for treating diseases related to the immune system
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820169 inhibiting the activity of tumor necrosis factor TNF in a patient having rheumatoid arthritis or psoriatic arthritis, by administering a composition comprising an effective amount of human anti-TNF antibody comprising a heavy chain variable region comprising SEQ ID NO:7 and a light chain variable
10/26/2010US7820160 Midkine inhibitory compositions for the treatment of angiostenosis
10/26/2010US7820157 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine
10/26/2010CA2526893C Inhibition of the expression of huntingtin gene
10/26/2010CA2351887C Psca: prostate stem cell antigen and uses thereof
10/26/2010CA2326501C Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
10/26/2010CA2291138C Transplants for myocardial scars and method and cellular preparations therefor
10/26/2010CA2271438C Method for producing recombinant virus
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010WO2010121149A2 Vertebral endplate connection implant and method
10/21/2010WO2010121074A1 Modulation of inflammatory responses by factor xi
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 870